COMMUNIQUÉS West-GlobeNewswire

Annovis Completes Full Patent Transfer to Crystal Buntanetap
07/08/2025
Annovis achieves comprehensive intellectual property (IP) protection now covering both the original semi-crystalline and new crystalline forms of buntanetap. Both forms are covered by a total of 13 patent families. All [...]
Route 92 Medical Files Patent Infringement Suit Against Balt
07/08/2025
SAN MATEO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, filed a patent [...]
MBX Biosciences Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
07/08/2025
Topline results for the Phase 2 Avail™ trial of canvuparatide in hypoparathyroidism on track for Q3 2025 Imapextide (MBX 1416) Phase 2a trial initiation in patients with post-bariatric hypoglycemia anticipated in Q3 [...]
Stryker declares an $0.84 per share quarterly dividend
07/08/2025
Portage, Michigan, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.84 per share payable October 31, 2025, to shareholders of record at [...]
Privia Health Reports Second Quarter 2025 Financial Results
07/08/2025
Very Strong First Half Performance Across All Key Operating and Financial Metrics Implemented Providers +13.8% and Practice Collections +18.5% compared to 2Q’24 Guidance Raised to Above High End of Range for Practice [...]
Dentsply Sirona Reports Second Quarter 2025 Results
07/08/2025
Net sales of $936 million decreased (4.9%) , decreased (6.7%) in constant currency including a (3.2%) Byte sales impact GAAP gross margin of 52.4% , GAAP net loss per share of ($0.22) Adjusted gross margin of 55.9% , [...]
LifeStance Reports Second Quarter 2025 Results
07/08/2025
SCOTTSDALE, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the second [...]
Enovis Announces Second Quarter 2025 Results
07/08/2025
Continued commercial momentum with second-quarter sales growth of 7% on a reported basis Second-quarter Reconstructive sales grew 11% year-over-year on a reported basis Wilmington, DE, Aug. 07, 2025 (GLOBE NEWSWIRE) -- [...]
DeepHealth, a RadNet Subsidiary, Receives FDA Clearance for Remote Scanning Solution, TechLive™
07/08/2025
TechLive™ is a vendor-agnostic integrated solution enabling remote scanning of MR, CT, PET/CT, and Ultrasound procedures Amidst radiology technologist shortages, remote scanning in a command center configuration enables [...]
Accumulus Synergy crée Accumulus Technologies pour développer sa plateforme réglementaire éprouvée et accélérer l’accès mondial aux thérapies
07/08/2025
BURLINGAME, Californie, 07 août 2025 (GLOBE NEWSWIRE) -- Dans une démarche audacieuse visant à accélérer l’innovation réglementaire et à répondre à la demande mondiale croissante, Accumulus Synergy, une association [...]
IBA Notice of Half Year 2025 Results and Conference Call
07/08/2025
HY25 results webcast to take place on Thursday, 28 August 2025 at 3pm CEST Louvain-la-Neuve, Belgium, 07 August 2025 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, [...]
IBA : Publication des résultats du premier semestre 2025 et conférence web
07/08/2025
La conférence sur les résultats des six premiers mois de 2025 aura lieu le jeudi 28 août 2025 à 15h00, heure de Bruxelles Louvain-la-Neuve, Belgique, le 7 août 2025 - IBA (Ion Beam Applications S.A le leader mondial des [...]
SNIPR BIOME Raises EUR 35 Million Series B Financing to Advance CRISPR-Medicines Targeting Antimicrobial Resistance
07/08/2025
COPENHAGEN, Denmark, Aug. 07, 2025 (GLOBE NEWSWIRE) -- SNIPR Biome ApS (“SNIPR”), the company pioneering the development of microbial CRISPR-medicine, today announced the close of a EUR 35 million Series B raise with [...]
Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information
07/08/2025
Saint Herblain (France), August 7, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the FDA has removed its recommended pause in the use of IXCHIQ ® in individuals [...]
Valneva annonce la levée de l’arrêt temporaire de la FDA sur l’utilisation du vaccin contre le chikungunya IXCHIQ® chez les personnes âgées et une mise à jour des caractéristiques du produit
07/08/2025
Saint Herblain (France), le 7 août 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd’hui la levée de l’arrêt temporaire de l’agence de santé américaine Food [...]
Sandoz delivers strong H1 2025 results, with accelerated sales growth in the second quarter
07/08/2025
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Basel, August 7, 2025 – Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in generic and biosimilar medicines, today presents its [...]
Sana Biotechnology Announces Pricing of Public Offering
07/08/2025
SEATTLE, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has priced its [...]
CORRECTING and REPLACING - Inotiv Reports Third Quarter Financial Results for Fiscal 2025 and Provides Business Update
07/08/2025
In a release issued under the same headline on August 6, 2025 by Inotiv, Inc. (NASDAQ: NOTV), please note that the amount of the recent draw request on the revolving credit facility has been corrected. The corrected [...]
Extendicare Announces 2025 Second Quarter Results
06/08/2025
MARKHAM, Ontario, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and six months ended June 30, 2025. Second Quarter 2025 Highlights [...]

Pages